Anti-ST2 monoclonal antibody inhibits eosinophil infiltration in Angiostrongylus cantonensis-infected mice

Journal of Microbiology, Immunology and Infection

Volumn 49, Issue 1, 2016, Pages 91-96

  Chuang, Chih Cheng ^a,b   Chen, Chi Wu ^c   Huang, Yu Tzu ^a   Du, Wen Yuan ^a  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c VANUNG UNIVERSITY   (Taiwan)

Author keywords

Angiostrongylus cantonensis; Interleukin 33; ST2

Indexed keywords

ANTIPARASITIC AGENT; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 33; INTERLEUKIN 5; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY ST2; SOMATOSTATIN RECEPTOR 2; UNCLASSIFIED DRUG; IL1RL1 PROTEIN, MOUSE; INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN; INTERLEUKIN RECEPTOR;

ANGIOSTRONGYLIASIS; ANGIOSTRONGYLUS CANTONENSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHIL INFILTRATION; EOSINOPHILIC MENINGITIS; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOCYTE DIFFERENTIAL COUNT; MALE; MOUSE; NONHUMAN; PERIPHERAL CIRCULATION; PROTEIN EXPRESSION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; IMMUNOLOGY; MENINX; PATHOLOGY; STRONGYLE INFECTION; TREATMENT OUTCOME;

ANGIOSTRONGYLUS CANTONENSIS; ANIMALS; ANTIBODIES, MONOCLONAL; EOSINOPHILS; INTERLEUKIN-1 RECEPTOR-LIKE 1 PROTEIN; MALE; MENINGES; MICE, INBRED C57BL; RECEPTORS, INTERLEUKIN; STRONGYLIDA INFECTIONS; TREATMENT OUTCOME;

EID: 84958034800     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2014.01.009     Document Type: Article

References (35)

1. Tsai H.C., Lee S.S., Huang C.K., Yen C.M., Chen E.R., Liu Y.C. Outbreak of eosinophilic meningitis associated with drinking raw vegetable juice in southern Taiwan. Am J Trop Med Hyg 2004, 71:222-226.
2. Furugen M., Yamashiro S., Tamayose M., Naha Y., Miyagi K., Nakasone C., et al. Elsberg syndrome with eosinophilic meningoencephalitis caused by Angiostrongylus cantonensis. Intern Med 2006, 45:1333-1336.
3. Wang J., Qi H., Diao Z., Zheng X., Li X., Ma S., et al. An outbreak of angiostrongyliasis cantonensis in Beijing. J Parasitol 2010, 96:377-381.
4. Yen C.M., Chen E.R. Detection of antibodies to Angiostrongylus cantonensis in serum and cerebrospinal fluid of patients with eosinophilic meningitis. Int J Parasitol 1991, 21:17-21.
5. Sugaya H., Aoki M., Abe T., Ishida K., Yoshimura K. Cytokine responses in mice infected with Angiostrongylus cantonensis. Parasitol Res 1997, 83:10-15.
6. Du W.Y., Liao J.W., Fan C.K., Su K.E. Combined treatment with interleukin-12 and mebendazole lessens the severity of experimental eosinophilic meningitis caused by Angiostrongylus cantonensis in ICR mice. Infect Immun 2003, 71:3947-3953.
7. Intapan P.M., Kittimongkolma S., Niwattayakul K., Sawanyawisuth K., Maleewong W. Cerebrospinal fluid cytokine responses in human eosinophilic meningitis associated with angiostrongyliasis. J Neurol Sci 2008, 267:17-21.
8. Peng H., Sun R., Zhang Q., Zhao J., Wei J., Zeng X., et al. Interleukin 33 mediates type 2 immunity and inflammation in the central nervous system of mice infected with Angiostrongylus cantonensis. J Infect Dis 2013, 207:860-869.
9. Weller P.F. Eosinophils: structure and functions. Curr Opin Immunol 1994, 6:85-90.
10. Meeusen E.N., Balic A. Do eosinophils have a role in the killing of helminth parasites?. Parasitol Today 2000, 16:95-101.
11. Perez O., Capron M., Lastre M., Venge P., Khalife J., Capron A. Angiostrongylus cantonensis: role of eosinophils in the neurotoxic syndrome (Gordon-like phenomenon). Exp Parasitol 1989, 68:403-413.
12. Chuang C.C., Chen C.W., Fan C.K., Su K.E., Tsai Y.T., Chen C.L., et al. Angiostrongylus cantonensis: apoptosis of inflammatory cells induced by treatment with mebendazole or/and interleukin 12 in mice. Exp Parasitol 2007, 115:226-232.
13. Moqbel R., Lacy P. New concepts in effector functions of eosinophil cytokines. Clin Exp Allergy 2000, 30:1667-1671.
14. Shi H.Z. Eosinophils function as antigen-presenting cells. J Leukoc Biol 2004, 76:520-527.
15. Bartemes K.R., Cooper K.M., Drain K.L., Kita H. Secretory IgA induces antigen-independent eosinophil survival and cytokine production without inducing effector functions. J Allergy Clin Immunol 2005, 116:827-835.
16. Yamaguchi Y., Suda T., Ohta S., Tominaga K., Miura Y., Kasahara T. Analysis of the survival of mature human eosinophils: interleukin-prevents apoptosis in mature human eosinophils. Blood 1991, 78:2542-2547.
17. Stern M., Meagher L., Savill J., Haslett C. Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol 1992, 148:3543-3549.
18. Greenfeder S., Umland S.P., Cuss F.M., Chapman R.W., Egan R.W. Th2 cytokines and asthma. The role of interleukin-in allergic eosinophilic disease. Respir Res 2001, 2:71-79.
19. Ichinose M., Barnes P.J. Cytokine-directed therapy in asthma. Curr Drug Targets Inflamm Allergy 2004, 3:263-269.
20. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
21. Kurowska-Stolarska M., Hueber A., Stolarski B., McInnes I.B. Interleukin-33: a novel mediator with a role in distinct disease pathologies. J Intern Med 2011, 269:29-35.
22. Préfontaine D., Lajoie-Kadoch S., Foley S., Audusseau S., Olivenstein R., Halayko A.J., et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 2009, 183:5094-5103.
23. Du W.Y., Chen C.W., Lin F.K., Chuang C.C. IL-33 mediates the expressions of IL-and IL-13 in Angiostrongylus cantonensis-infected mice. Exp Parasitol 2013, 135:587-594.
24. Hayakawa H., Hayakawa M., Kume A., Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 2007, 282:26369-26380.
25. Kearley J., Buckland K.F., Mathie S.A., Lloyd C.M. Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med 2009, 179:772-781.
26. Kittimongkolma S., Intapan P.M., Laemviteevanich K., Kanpittaya J., Sawanyawisuth K., Maleewong W. Eosinophilic meningitis associated with angiostrongyliasis: clinical features, laboratory investigations and specific diagnostic IgG and IgG subclass antibodies in cerebrospinal fluid. Southeast Asian J Trop Med Public Health 2007, 38:24-31.
27. Lopez A.F., Sanderson C.J., Gamble J.R., Campbell H.D., Young I.G., Vadas M.A. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988, 167:219-224.
28. Hsu C.L., Neilsen C.V., Bryce P.J. IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS One 2010, 5:e11944.
29. Hung L.Y., Lewkowich I.P., Dawson L.A., Downey J., Yang Y., Smith D.E., et al. IL-33 drives biphasic IL-13 production for noncanonical type 2 immunity against hookworms. Proc Natl Acad Sci U S A 2013, 110:282-287.
30. Moritz D.R., Rodewald H.R., Gheyselinck J., Klemenz R. The IL-receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. J Immunol 1998, 161:4866-4874.
31. Löhning M., Stroehmann A., Coyle A.J., Grogan J.L., Lin S., Gutierrez-Ramos J.C., et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci U S A 1998, 95:6930-6935.
32. Cherry W.B., Yoon J., Bartemes K.R., Iijima K., Kita H. A novel IL-family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol 2008, 121:1484-1490.
33. Suzukawa M., Koketsu R., Iikura M., Nakae S., Matsumoto K., Nagase H., et al. Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. Lab Invest 2008, 88:1245-1253.
34. Liu X., Li M., Wu Y., Zhou Y., Zeng L., Huang T. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem Biophys Res Commun 2009, 386:181-185.
35. Humphreys N.E., Xu D., Hepworth M.R., Liew F.Y., Grencis R.K. IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J Immunol 2008, 180:2443-2449.